PROGRESS: Implementing a hybrid decentralized clinical trial to advance precision oncology and improve cancer care quality and equity across North Carolina oncology practices.
70 Background: Rates of comprehensive molecular profiling (CMP), use of evidence-based genome-informed therapy (GIT), and clinical trial participation remain low despite being markers of high-quality cancer care. PROGRESS is an interventional study evaluating the impact of a centralized precision oncology navig...